Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Multiple Myeloma, Date of authorisation: 25/05/2022, Revision: 4, Status: Authorised
TO: